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Abstract
We present the clinical implementation of a novel hybrid
system that combines magnetic resonance imaging
(MRI) and near- infrared (NIR) optical measurements
for the noninvasive study of breast cancer in vivo.
Fourteen patients were studied with a MR-NIR proto-
type imager and spectrometer. A diffuse optical tomo-
graphic scheme employed the MR images as a priori
information to implement an image-guided NIR local-
ized spectroscopic scheme. All patients who entered
the study also underwent gadolinium-enhanced MRI
and biopsy so that the optical findings were cross-
validated with MR readings and histopathology. The
technique quantified the oxy- and deoxyhemoglobin of
five malignant and nine benign breast lesions in vivo.
Breast cancers were found with decreased oxygen
saturation and higher blood concentration than most
benign lesions. The average hemoglobin concentration
( [H]) of cancers was 0.130±0.100 mM, and the average
hemoglobin saturation (Y ) was 60±9% compared to
[H]=0.018±0.005 mM and Y=69±6% of background
tissue. Fibroadenomas exhibited high hemoglobin con-
centration [H]=0.060±0.010 mM and mild decrease in
oxygen saturation Y=67±2%. Cysts and other normal
lesions were easily differentiated based on intrinsic
contrast information. This novel optical technology can
be a significant add-on in MR examinations and can be
used to characterize functional parameters of cancers
with diagnostic and treatment prognosis potential. It is
foreseen that the technique can play a major role in
functional activation studies of brain and muscle as
well.
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Introduction
Light offers unique wavelength-dependent contrast mecha-
nisms in tissues; the scattering, absorption, and fluorescence
of intrinsic tissue chromophores or extrinsically administered
chromophores contain information about anatomy, physiol-
ogy, biochemistry, and molecular function [1]. These unique
contrast mechanisms have driven recent developments for
imaging deep into tissue using near- infrared (NIR) radiation
[2-4]. NIR light can penetrate several centimeters into tissue
before it is attenuated below detection. The main intrinsic
mechanisms of NIR light attenuation in tissue are the
scattering due to index of refraction variations of the cellular
organelles [5,6 ], and absorption mainly due to oxy- and
deoxyhemoglobin, and in lesser degree due to water and
lipids [5 ].
Diffusion theory [7 ] has been employed over the last
decade to model the propagation of highly scattered NIR
photons in deep tissue and provided rigorous mathemat-
ical models for noninvasive quantification of the optical
properties of large organs. Quantification of the average
optical properties of tissue at multiple wavelengths
constitutes diffuse optical spectroscopy (DOS), which
has been used to investigate muscle [8,9 ], brain activation
[10-12], and assess physiological responses from normal
and malignant breast tissues [5]. The combination of
multiple NIR light measurements through tissue at several
projections, using appropriate mathematical models based
on diffusion theory, led to a new tomographic technique
termed diffuse optical tomography (DOT). This technique
has been recently applied clinically to produce quantified
tomographic images of tissue chromophore concentra-
tions in imaging brain function [4] and breast cancer
[2,3].
In this paper, we present the clinical application of a
method that combines concurrent optical and magnetic
resonance (MR) measurements to perform magnetic
resonance imaging (MRI) -guided DOS and noninvasively
retrieve functional tumor characteristics in deep tissue.
This approach originates a novel imaging and spectro-
scopic modality that merges the information content of MR
and optical contrast into one scanner. Concurrent DOT
and MRI as stand-alone imaging modalities have been
performed recently for validation of DOT performance [3].
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But the combination of the optical and MR measure-
ments into the same tomographic scheme yields addi-
tional benefits that cannot be achieved simply by
acquiring MR and optical images as stand-alone tech-
niques. This is because the use of a priori information,
such as the anatomical or functional information from
MRI, can significantly improve the quantification accuracy
of the optical method by constraining the DOT inverse
problem [13-15]. Therefore, tissue chromophores and
fluorochromes associated with function and disease can
be quantified with high accuracy and resolution compared
to other noninvasive techniques. The optical and MR
examinations are fully compatible and, given the cost
efficiency of optical systems, it would be anticipated
that hybrid MR–optical systems could be easily imple-
mented to augment the information content of the MR
examination.
This work had three aims. The first aim was to
demonstrate the first reported clinical implementation of
MR-guided DOS, and illustrate practical aspects of the
technique. The second aim was to noninvasively quantify the
optical properties of breast tumors in vivo and obtain
localized measurements of hemoglobin concentration and
oxygenation. Finally, the third aim was to obtain insight on
the distribution of cancer-associated optically detected
intrinsic signals. The assessment of tumor function, i.e.,
vascularization and oxygenation status, can be associated
with angiogenesis and cancer-specific hypoxia and may
correlate with malignancy andmetastatic potential. Localized
DOS may be the method of choice for such investigations
because it can offer higher quantification accuracy than the
existing conventional NIR spectroscopic and tomographic
methods.
The remainder of this paper briefly describes the hybrid
MR–DOT instrument and breast examination protocol,
presents the theory and practical aspects of localized DOS,
and reports our findings on 14 patients.
Materials and Methods
MR–DOT Instrument
The MR scanner employed was a 1.5-T imager
(Signa; GE Medical Systems, Milwaukee, WI), version
5.4 software. The optical instrument was a custom-built
time domain optical imager and spectrometer that has
been described in the past [12,16]. In brief, the optical
instrument used laser diodes to produce short photon
pulses (50 ps full width at half maximum) that excite the
tissue under investigation. Two wavelengths at 780 and
830 nm were used. At more recent examinations, an
additional wavelength (690 nm) was added. The average
power for all wavelengths was 40 W (Food and Drug
Administration Class I ). The pulse repetition rate was 5
MHz. An optical switch (Dicon Fiberoptics, Richmond,
CA) was used to time-multiplex the source light to 24
positions on the breast using single 100/140 m core/
clad graded index fibers. The detection optical system
used eight fiber bundles for parallel photon collection.
Photon detection was achieved using the R5600U-50
GaAs photomultiplier tubes (Hamamatsu, Bridgewater,
NJ). The arrival of single photons was time-resolved
using the SPC-300 single-photon counting time-correlat-
ing system (PicoQuant, Berlin, Germany). Both source
fibers and fiber bundles were 10 m long so that the
instrument was placed outside the MR scanner room to
avoid electromagnetic interference.
During examination, the breast was compressed gently
between two plates, as shown in Figure 1. The plates held
the optical fibers and the receiving MR radio- frequency
coils [17]. Specially designed fiducials containing water
and CuSO4 were attached onto the plates. The fiducials
appear on the MR images for registration purposes. All
source fibers were mounted on one plate, forming a 38
grid array with adjacent fiber separations of 1.25 cm. All
detector fiber bundles were mounted on the other plate,
forming a 24 grid array with adjacent fiber separation of
2.5 cm.
Localized DOS
The optical instrument employed in this study can perform
DOT, DOS, and image-guided DOS. Localized DOS can be
implemented by combining a typical DOT problem at multiple
wavelengths with a priori information (provided herein by
MRI) and effectively converts an ‘‘imaging’’ problem to a
lesion ‘‘characterization’’ problem. In the following, we briefly
explain the basic formulation steps of localized DOS, for
presentation completeness.
DOT We begin this description from the simple perturbative
tomographic problem, which can be written in matrix form
as:
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The left -most vector of Eq. (1) is the measurement
vector, i.e., it contains measurements of the light detected at
the tissue boundary at position r!d, due to a source at position
r!s. In the general case, the source light can bemodulated at
different frequencies !; therefore, the measurement vector
contains measurements of multiple source detector pairs at
different modulation frequencies. For o number of sources, p
number of detectors, and q number of frequencies, the length
of the measurement vector is m=opq.
The right-most vector is the vector of unknowns. For
tomographic purposes, the volume of interest is segmented
into a number of voxels. The volume has an average
absorption coefficient a0 and an average diffusion coef-
ficient D0. Each voxel is then associated with an unknown
absorption perturbation relative to a0. Solving the problem
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for the unknown optical properties retrieves a three-
dimensional quantified image of the absorption distribution.
For nx, ny, nz voxels along the three dimensions, the vector
of unknowns is n=nxnynz. For three-dimensional
reconstructions, this vector can easily become very large.
Eq. (2) assumes that no diffusion coefficient perturbations
exist for simplicity. Diffusion perturbations can be handled
similarly to absorption perturbations and their contribution
can be approximated [18] as a linear superposition to
Eq. (1).
The matrix in the middle is the weight matrix, which
maps the space of unknowns to the space of measure-
ments. Each of the elements Wmn describes the effect that
the optical property perturbation of voxel n has on the
measurement m. The exact form of the weights is given
elsewhere [18].
Using a priori information Eq. (1) represents the general
formulation of DOT using perturbation theory. Let us
assume that we superimpose a stack of MR images onto
the DOT discretization mesh nxnynz. Then we can
relate each optical mesh voxel with different breast tissues.
For example, a group of voxels could coincide with purely
adipose tissue, others with purely parenchymal tissue, and
others with mixed patches of adipose and parenchymal
tissues as shown in Figure 2. Figure 2 depicts a two-
dimensional representation of the three-dimensional prob-
lem and uses large DOT voxels for presentation reasons.
Then we can assume that all optical mesh voxels related
with the same tissue type have the same absorption
perturbation að r!Þ. In practical terms, this assumption
allocates a different average að r!Þ to each of the selected
tissue types. Hence, the number of unknowns in Eq. (1)
reduces to the number T of unknown tissue types assumed
(e.g., adipose, parenchymal, tumor, mixed, and so forth).
Accordingly, all the columns of the weight matrix in Eq. (1)
that correspond to voxels of the same tissue structure can
be grouped together and Eq. (1) can be written as:
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where Q1, Q2, . . . QT indicate the number of voxels
corresponding to each of the T different tissues assumed.
Eq. (2) typically reduces the number of unknowns by three
orders of magnitude while it employs the same number of
measurements used in the DOT problem. Therefore, it
produces a highly overdetermined system of equations ( i.e.,
a system of equations with significantly more measurements
than unknowns) and considerably reduces the complexity
and computation requirements of the inversion compared to
the corresponding DOT problem. Eq. (2) can be solved with
higher accuracy than the typical DOT inversion problems
[13,14], which are usually underdetermined ( i.e., have more
unknowns than measurements) and therefore cannot be
Figure 1. Patient placement into the MR bore. Source fibers were attached on
the inner side of the pedant breast, and detector fiber bundles were placed on
the outer side of the breast, using appropriate plates that compress the breast
softly. Light was shined sequentially through the 24 source fibers and acquired
in parallel on the other side by the detector fiber bundles so that multiple
projections were collected for each source fiber.
Figure 2. Two -dimensional representation of the three - dimensional problem
of overlaying the optical mesh onto the MR image. Different voxels of the
optical mesh correspond to different tissue types or combinations of them. By
setting appropriate thresholds, each of the optical mesh voxels can be
assigned to one tissue type that has an average absorption coefficient and an
average reduced scattering coefficient that is common to all voxels of the
same tissue type.
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inverted with high fidelity, especially in the case of hetero-
geneous, tissue- like media [19].
Two-Tissue Merit Function
Eq. (2) serves as an example of a localized DOS
application. In practice, different segmentation schemes will
yield different sets of unknowns. The different possibilities
further expand if diffusion perturbations are implemented as
well. In this work, we opted for a merit function that would be
physiologically relevant while preserving maximum inversion
robustness. We found a two- tissue merit function, which fits
only for the absorption perturbation of two tissues (struc-
tures), to be a balanced choice of available alternatives. We
assumed that the breast consisted of a ‘‘background
structure’’ which was a mix of adipose, parenchymal, and
other tissues and the ‘‘tumor structure’’ which incorporated
voxels that corresponded only to tumors. In accordance to
Eq. (2), the selected merit function can be written as:
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where Q1 are the optical mesh voxels coinciding with the
tumor structure and Q2 all the remaining voxels. The two-
tissue merit function has been experimentally evaluated in
the past using single absorbers embedded in otherwise
homogeneous phantoms, which simulated the geometry and
average optical properties of the breast [15,20 ], and
demonstrated linear response and good quantification
accuracy to absorption values up to 0.15 cm1. This merit
function has been also evaluated using simulated data on
highly heterogeneous backgrounds [21] and demonstrated
quantification accuracy within ±5% of the actual absorption
of the tumor structure, for varying background heterogeneity,
i.e., the ratio and the spatial appearance of adipose and
parenchymal tissue.
Eq. (3) does not score independently the composition of
different tissues involved in the background structure but
assumes an average contribution of all background tissues.
The main postulation is that the absorption coefficient of the
background optical heterogeneity attains a distribution,
which, although is not necessarily random, perturbs the
propagating photon wavefront randomly so that this pertur-
bation appears at the detection front as spatially uncorre-
lated noise. Furthermore, Eq. (3) assumes a similar random
pattern for the diffusion coefficient heterogeneity D ð r!Þ.
Some tumors will actually exhibit scattering changes due to
neoplastic structural malformations [6]. The underlying
assumption of Eq. (3) is that the D ð r!Þ of tumors
contributes to a general random pattern of D ð r!Þ variation
seen along the breast tissue due to the ductal system or the
changes between adipose and parenchymal tissue that will
also cause a random perturbation on the propagating photon
wave.
Localized DOS is insensitive to random noise because a
highly overdetermined system is inverted ( in this implemen-
tation, more than 200 measurements for two unknowns).
Therefore, Eq. (3) is very robust and accurate within its
assumptions. Conversely, if these assumptions are not
satisfied, there may arise systematic errors that could
eventually compromise the accuracy of the method. Sensi-
tivity to systematic errors was reduced through the a
Backgr
term. In fact, the role of a
Backgr in Eq. (3) was not to
determine the average background absorption perturbation
of the mixed tissue structure, because the latter was
determined with DOS and not localized DOS, as will be
explained in the Data Analysis section, but to account for
systematic errors such as theoretical modeling uncertainties
and errors in the calculation of the background optical
properties. a
Backgr can also partly compensate for nonuni-
form background optical property distributions that result in
nonrandom wavefront perturbations. Therefore, the a
Backgr
converges to a background absorption coefficient (baseline)
that will contain experimental and modeling uncertainties,
whereas the parameter a
Tumor fits only for correlated
contrast that it is spatially consistent with the selected
suspicious lesion. This performance of Eq. (3) with hetero-
geneous media and its low sensitivity to its assumptions
have been demonstrated [20,21].
Nevertheless, the appearance of systematic errors
cannot be completely accounted for using Eq. (3). For
example, spatially dependent geometrical errors, such as
nonparallel compression plates, or significant deviations
from a random background variation in the absorption or
reduced scattering coefficients will be only partly accounted
for by a
Backgr and may propagate in the calculation of
a
Tumor. The presence of systematic errors was examined
on a per-patient basis. Spatial dependence of the breast
average optical properties was investigated for each source
detector pair. The typical variation of the average optical
properties taken from different sides of the breast was within
10%, including experimental uncertainties. Occasionally,
measurements that were converging to abnormal average
optical properties, indicating deviation from a random pattern
or other systematic errors, were excluded from Eq. (3).
Spectroscopy
At earlier patient examinations (n=9), two wavelengths
were used at 780 and 830 nm. One more wavelength at
690 nm was added at more recent examinations (n=5).
For each suspicious lesion, a system of two or three
equations (depending on the number of wavelengths
employed) and two unknowns (oxygenated and deoxy-
genated hemoglobin concentration) was solved using direct
inversion ( for two equations) and quadratic fitting ( for three
equations). Each equation of this system is written as
a
="HBO2
 [HBO2]+"HB [HB]+c, where "HBO2 and
"HB
 are the extinction coefficients for oxygenated and
deoxygenated hemoglobin at wavelength ; [HBO2] [HB]
are the concentrations of oxygenated and deoxygenated
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hemoglobin, respectively; and c is the background ab-
sorption at  due to water and fat. The background ab-
sorptions assumed, based on water- to- lipid ratio of 2.5,
were c830=0.012 cm1, c780=0.01 cm1 and c690=0.003
cm1. Although the third wavelength could be used to
solve for c, it has been shown [22] that the quantification
accuracy improves if it is used in the manner employed in
this work. Then the blood concentration [H] and the
hemoglobin saturation Y were calculated as [H]=[HBO2]+
[HB] and Y=[HBO2] / [H].
Examination Protocol
The simultaneous MR and DOT study and informed
consent form were approved by the institutional review
board. Except for control cases, patients entering the study
had a previous suspicious mammogram or palpable lesion
and were scheduled for excisional biopsy or surgery. Written
informed consent was obtained from all participants.
Patient placement followed standard procedures used
for the MR examination. The patient assumed the prone
position (Figure 1 ) with the breasts falling away from the
chest wall and into an H-shaped coil holder. The two
compression plates were positioned parallel to the sagittal
plane and ensured contact of the optical fibers onto the
tissue.
The simultaneous examination protocol (Figure 3 ) was
designed so that DOT and localized DOS measurements of
intrinsic (oxy- and deoxyhemoglobin) and extrinsic con-
trasts ( intravenously administered chromophores) were
performed. Here we describe only the measurements that
were employed in localized DOS of oxy- and deoxyhemo-
globin, as shown in Figure 2. A description of the complete
examination protocol can be found elsewhere.
The MRI protocol consisted of 1) an axial T1 Spin Echo
(SE) (TR/TE 500/14 FOV 24) localizer; 2) a sagittal
T1-weighted SE (TR/TE 500/14 FOV 16); 3) a sagittal
T2-weighted, fat -saturated fast SE (TR/TE 5000/120 FOV
16); and 4) a sagittal, three-dimensional, fat -saturated
gradient echo sequence (TR/TI /TE 9.3/27/2.2, acquisition
matrix 512512 FOV 16; slice thickness 2.5–3). The last
sequence (4) acquired one pre-gadolinium and three post -
gadolinium sets of images to investigate the gadolinium
distribution. Gadolinium was administered intravenously at
0.1 mmol /kg and demonstrated no change in the optical
properties.
The localized DOS examination protocol of intrinsic
contrast ran simultaneously with the MR protocol. First, a
measurement with the laser light off was performed to
obtain dark current and background light noise. Then the
light power was optimally adjusted so that none of the
detectors was saturated. Subsequently, all sources were
scanned to obtain measurements of breast intrinsic contrast
(SET I). This measurement acquired the total photon field
through the breast. At the end of the examination, a
measurement on a resin phantom with absorption coef-
ficient of a=0.03 cm
1 and s
0 =10.5 cm1 at 780 nm
(a=0.028 cm
1, s
0 =9.8 cm1 at 830 nm) was performed
(SET VI). The phantom measurement acquired the baseline
that was used to normalize the total photon field obtained
through the breast [19]. The collection time for each source
was 7 s.
Data Analysis
The first step was to calculate the average optical
properties of the breast of each patient examined. We fitted
the time domain data obtained for each source detector
pair to the time-dependent solution of the diffusion
equation assuming slab geometry and extrapolated boun-
dary condition, using the Levenberg–Marquardt procedure.
The specifics of the fit have been described [12]. The
optical properties obtained for different source detector
pairs were averaged to yield global optical properties of
each breast.
The second step was to superimpose a DOT mesh on the
corresponding MRI stack and segment the MRI image to
the tumor and background structures. This process was
performed using custom-made image analysis software
developed specifically for that purpose [21]. The output of
Figure 3. The experimental simultaneous MR–optical examination protocol.
Only the segments relevant to the measurement of intrinsic contrast are
shown.
Figure 4. Two -dimensional plot of the hemoglobin saturation and concen-
tration measured from selected malignant and benign breast lesions using
MR-guided DOS. The baseline measurements represent average values
calculated from each breast examined. The normal lesions correspond to
areas enhancing on MR after gadolinium administration, but were not
identified as suspicious on the X - ray mammogram or diagnosed as malignant
by MR.
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this process was a DOT mesh with voxels identified either as
belonging to the suspicious lesion(s) or to the rest of the
breast. MR segmentation was based on the first gradient
echo MRI sequence acquired immediately after gadolinium
administration. The typical DOT voxel selected was 333
mm3. The number of voxels varied with breast size. The
suspicious lesion was manually identified for each examina-
tion on the MR stack of images using a user interface
provided within the homemade image analysis program.
DOT mesh voxels that coincided with the suspected lesion
and were enhancing under gadolinium administration were
assumed as vascular and the source of contrast for the
optical examinations. Even if lesions were enhancing else-
where in the breast, they were not included in the tumor
structure. Therefore, if vascular, those lesions were con-
tributing to the ‘‘biological’’ noise.
The third step was the construction of Eq. (3) and
its subsequent 2 minimization. This minimization was
the equivalent of minimizing the function f ðaÞ ¼
ðUWaÞ2, where a is the vector of unknown per-
turbations in Eq. (3),U is the vector of measurements, and
W is the weight matrix. The minimization process is based on
the simplex algorithm provided within the MATLAB software
package (Mathworks, Natick, MA). The vector of measure-
ments is appropriately normalized using the Rytov approx-
imation [3]. This normalization includes correction for
differences in the average optical properties and thickness
between the breast and the calibration phantom. The exact
correction method has been reported previously [19]. We
note that the weight matrix in Eq. (3) is calculated for the
average optical properties of each breast examined and
therefore inherently describes the average contributions of
the different tissue types involved in the background
structure and effectively accounts for possible lipid /adipose
or other tissue compositional changes as a function of age or
menstrual cycle [5 ] in different patients. The final output of
the fitting process was the absorption perturbations of the
background and tumor structures.
The final step was the calculation of hemoglobin
saturation and concentration as described in the section
titled Spectroscopy.
Results
Figure 4 plots the hemoglobin saturation of the lesions
investigated as a function of their hemoglobin concentration.
The filled circles correspond to the five cancerous lesions
encountered. The clear circles indicate benign tumors. The
exact pathologies and average sizes of malignant and
benign tumors are tabulated in Table 1. The triangles
correspond to normal lesions that were not examined as
suspicious but were retrospectively found as structures that
demonstrated higher gadolinium uptake than the average
background. Finally, the diamonds indicate the average
saturation Y and hemoglobin concentration [H] values
obtained for each breast as described in the first step of
the Data Analysis section. This plot allows for a two-
dimensional characterization of lesions. In general, the
cancerous lesions appear of lower oxygen saturation and
higher in hemoglobin concentration and they preferentially
distribute in the lower right corner of the chart. Some of the
normal lesions and one hyperplasia calculated also demon-
strated high vascular contrast but appear significantly oxy-
genated. Conversely, the two fibroadenomas seen in the
study yielded an increased vascular content and were also
found mildly hypoxic compared to average breast hemoglo-
bin saturation. Finally, the two cysts have a markedly low
absorption that yielded a small [H] value. The average
values for the cancers, the fibroadenomas, and the baseline
measurements are tabulated in Table 2. One of the tumors
demonstrated very high hemoglobin content but there was
no evidence that this measurement was an artifact and was
included in the calculations.
Figure 5 plots the hemoglobin concentration and the
saturation of the cancerous lesions as a function of their size.
A linear fit with and without the high [H] cancer lesion is
depicted. To the extent that the limited dataset allows a
conclusion, there is an apparent negative correlation between
tumor size and calculated hemoglobin concentration and
saturation. This observation could beexplainedasadecrease
of vascular density due to the irregular blood vessel develop-
ment, which also leads to oxygenation decrease.
The two-dimensional error bars plotted on Figure 4
indicate the standard deviation of the measurement
Table 1. MRI and Histopathological Diagnosis of the Cases Studied with
Localized DOS.
Case
Number
Size
( cm)
MRI
Diagnosis
Histopathological
Diagnosis
1 0.8 Carcinoma In situ and infiltrating
ductal carcinoma
2 1 Diffuse carcinoma Invasive carcinoma
3 1.2 Diffuse carcinoma Invasive lobular carcinoma
4 1.5 Invasive carcinoma Invasive and in situ
ductal carcinoma
5 1.3 Carcinoma In situ and infiltrating
ductal carcinoma
6 1.2 Fibroadenoma Fibroadenoma and benign
breast tissue with fibrosis
and focal duct hyperplasia
without atypia
7 1.3 Fibroadenoma Benign breast tissue with
fibrocystic change and
ductal hyperplasia
8 2 Multiple cysts –
9 1.2 No suspicious
enhancement
Fibrocystic changes with
extensive stromal fibrosis
10 2.5 Ductal hyperplasia Focal ductal hyperplasia
without atypia
Table 2. Average Hemoglobin Concentration and Saturation Values of
Selected Structures.
Lesion Number of
Observations
Y±SD (%) [H ]±SD (mM)
Cancer 5 60±9 0.130±0.100
Fibroadenomas 2 67±2 0.060±0.010
Breast tissue
(baseline )
14 69±6 0.018±0.005
352 Localized Diffuse Optical Spectroscopy Ntziachristos et al.
Neoplasia . Vol. 4, No. 4, 2002
expected based on a sensitivity analysis using highly
heterogeneous media [21] and assuming the signal - to-
noise ratio of each experimental measurement. The sensi-
tivity analysis also included typical systematic uncertainties,
such as typical errors in the measurement of background
optical properties or laser amplitude variations and jitter.
Generally, the saturation calculation is sensitive to random
noise because it is a ratio of two quantities but is not
significantly affected by systematic errors because a small
bias of both the numerator and denominator is effectively
canceled out. Conversely, systematic errors propagate
directly into hemoglobin concentration calculation, which is
the summation of oxy- and deoxyhemoglobin. Eq. (3) is
insensitive to random noise, but is susceptible to systematic
errors. Therefore, total hemoglobin calculation may be less
accurate than saturation calculations in this implementation if
systematic errors exist in the measurement as reflected by
the corresponding error bars. We also note that an unusually
large reduced scattering coefficient in the tumor structure is a
systematic error and, if present, will bias more the
hemoglobin concentration but not the saturation.
Discussion
The concurrent MR–DOT examination initiates a hybrid
modality in which both the high-resolution structural and
gadolinium enhancement pattern can be studied with MRI,
but also quantified hemoglobin concentration and saturation
are obtained. DOT is a complementary technique to MRI.
MRI targets primarily structure, whereas DOT assesses
function. MRI can also yield functional parameters such as
measures of deoxyhemoglobin, but using indirect measure-
ments of low sensitivity. The addition of localized DOS, which
directly targets and quantifies oxy- and deoxyhemoglobin
with high sensitivity, can significantly augment or validate
measurements of hemodynamics and aid in the study of
tissue functionality.
In our application, localized DOS probed the oxy- and
deoxyhemoglobin content of malignant and benign breast
lesions. The results seen on Figure 4 are consistent with
previous studies on cancer vascularization and oxygenation
[23,24]. Increased hemoglobin concentration is character-
istic of increased angiogenesis, a correlate of malignant
development [23]. Hypoxia has been observed with polaro-
graphic studies [25] in breast and other cancers such as
head and neck and cervical cancers and is generally linked to
tumoral abnormalities such as 1) compromised and aniso-
tropic microcirculation, 2) deterioration of the diffusion
geometry, and 3) tumor-associated anemia. The added
features of the optical examination yield significant informa-
tion for possible cancer characterization and prediction of the
treatment outcome. Generally, the level of oxygenation and
hemoglobin concentration of a lesion could serve as a
malignant indicator to be considered with the MRI features
for diagnosis and increasing the specificity of the hybrid
modality. Furthermore, genetic changes that increase tumor
aggressiveness and the incidence of metastases have been
linked to a decrease in oxygenation [25]. Laboratory and
clinical studies have suggested that hypoxia triggers the
expression of the hypoxia- inducible factor 1 (HIF-1), which
mediates the upregulation of angiogenic factors [26], such
as the vascular endothelial growth factor (VGEF) [27], and
augments the invasive and metastatic characteristics of
cancers [28,29]. It has also been established that hypoxic
tumors are refractory to chemotherapy or radiation therapy
[30]. Therefore, the hybrid MR–optical modality can further
assess important determinants for the outcome of cancer
treatment because adverse clinical outcome and tumor
hypoxia have been associated in clinical studies [28,29].
The purpose of this study was to demonstrate for the first
time the clinical application of a novel technique and obtain
an insight into the distribution of intrinsic optical contrast into
tissue. Due to the small statistical sample obtained, we
refrained from expanding our analysis to calculating stat-
istical measures of sensitivity and specificity. In fact, the
sensitivity of the developed hybrid modality would equal that
Figure 5. Plots of ( a ) hemoglobin concentration and (b ) saturation as a
function of lesion size.
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of MRI alone because our implementation requires prior
detection of a ‘‘suspicious lesion’’ by MRI. Whereas MRI has
high sensitivity in breast cancer detection, the hybrid system
could concentrate on the ability to obtain additional functional
features of identified suspicious lesions that could increase
the specificity of the MR examination and guide treatment
strategies. These possibilities should be proved with a larger
patient volume. Hopefully, this presentation could spark an
interest in pursuing larger studies where the inexpensive
optical technique is added to existing examination protocols
for simultaneous examinations with MRI or other imaging
technologies.
The hybrid examination modality can find several clinical
applications besides studying breast cancer, such as
assessing brain function or muscle activation. The imple-
mentation of multiple wavelengths and of higher DOT data
set may be potentially used to study additional tissue
absorbers of functional, pathological, or biochemical impor-
tance. Furthermore, an increased data set can allow the use
of a more complex merit function so that vascular parame-
ters of additional tissue types and tissue scattering could be
independently characterized as well. Finally, the method
could also find applications in the novel field of fluorescence-
mediated molecular tomography [31] by similarly improving
the characterization capacity of appropriate fluorescent
molecular markers [32] and yield molecular characterization
of deep-seated diseases in vivo.
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